Given the fact that all the pregnant women in our study were analyzed at the point of GDM diagnosis, i.e., before receiving medication, a question remains about whether insulin treatment in these patients could affect their leukocyte INSR gene expression? The gene discussed is INS; the disease is gestational diabetes.